2563 — Beijing Biostar Pharmaceuticals Co Balance Sheet
0.000.00%
Last trade - 00:00- HK$3.10bn
- HK$3.10bn
- CNY71.87m
Annual balance sheet for Beijing Biostar Pharmaceuticals Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final |
| Cash and Equivalents | |||
| Short Term Investments | |||
| Cash and Short Term Investments | 729 | 576 | 564 |
| Net Total Accounts Receivable | |||
| Net Total Receivables | 39 | 15.9 | 28.1 |
| Total Inventory | |||
| Prepaid Expenses | |||
| Total Other Current Assets | |||
| Total Current Assets | 805 | 634 | 699 |
| Gross Property, Plant And Equipment | |||
| Accumulated Depreciation | |||
| Net Property, Plant And Equipment | 118 | 136 | 177 |
| Net Intangible Assets | |||
| Long Term Investments | |||
| Other Long Term Assets | |||
| Total Assets | 926 | 772 | 913 |
| Accounts Payable | |||
| Accrued Expenses | |||
| Notes Payable / Short Term Debt | |||
| Current Portion of Long Term Debt / Capital Leases | |||
| Total Other Current Liabilities | |||
| Total Current Liabilities | 51.7 | 43.7 | 79.2 |
| Capital Lease Obligations | |||
| Total Long Term Debt | |||
| Total Debt | |||
| Total Other Liabilities | |||
| Total Liabilities | 58.4 | 49.2 | 122 |
| Common Stock | |||
| Retained Earnings (Accumulated Deficit) | |||
| Other Equity | |||
| Total Equity | 868 | 723 | 791 |
| Total Liabilities & Shareholders' Equity | 926 | 772 | 913 |
| Total Common Shares Outstanding |